Arthur G. Palmer and Oliver Hobert of the Department of Biochemistry & Molecular Biophysics were selected in recognition of their distinguished and continuing achievements in research.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
Doctoral students from VP&S and Mailman participated in a university-wide competition designed to help students develop communication skills for future careers. Two shared top honors.
Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?